These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30268973)

  • 1. Identification and Structure-Activity Relationship (SAR) of potent and selective oxadiazole-based agonists of sphingosine-1-phosphate receptor (S1P
    Liu T; Jin J; Chen Y; Xi Q; Hu J; Jia W; Chen X; Li Y; Wang X; Yin D
    Bioorg Chem; 2019 Feb; 82():41-57. PubMed ID: 30268973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3.
    Li Z; Chen W; Hale JJ; Lynch CL; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Parent SA; Bergstrom J; Card D; Forrest M; Quackenbush EJ; Wickham LA; Vargas H; Evans RM; Rosen H; Mandala S
    J Med Chem; 2005 Oct; 48(20):6169-73. PubMed ID: 16190743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists.
    Horan JC; Sanyal S; Choi Y; Hill-Drzewi M; Patnaude L; Anderson S; Fogal S; Mao C; Cook BN; Gueneva-Boucheva K; Fisher MB; Hickey E; Pack E; Bannen LC; Chan DS; Mac MB; Ng SM; Wang Y; Xu W; Modis LK; Lemieux RM
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4807-11. PubMed ID: 25241927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore-based design of novel oxadiazoles as selective sphingosine-1-phosphate (S1P) receptor agonists with in vivo efficacy.
    Quattropani A; Sauer WH; Crosignani S; Dorbais J; Gerber P; Gonzalez J; Marin D; Muzerelle M; Beltran F; Nichols A; Georgi K; Schneider M; Vitte PA; Eligert V; Novo-Perez L; Hantson J; Nock S; Carboni S; de Souza AL; Arrighi JF; Boschert U; Bombrun A
    ChemMedChem; 2015 Apr; 10(4):688-714. PubMed ID: 25735812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor.
    Vachal P; Toth LM; Hale JJ; Yan L; Mills SG; Chrebet GL; Koehane CA; Hajdu R; Milligan JA; Rosenbach MJ; Mandala S
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3684-7. PubMed ID: 16682185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P
    Xiao HY; Watterson SH; Langevine CM; Srivastava AS; Ko SS; Zhang Y; Cherney RJ; Guo WW; Gilmore JL; Sheppeck JE; Wu DR; Li P; Ramasamy D; Arunachalam P; Mathur A; Taylor TL; Shuster DJ; McIntyre KW; Shen DR; Yarde M; Cvijic ME; Marino AM; Balimane PV; Yang Z; Banas DM; Cornelius G; D'Arienzo CJ; Warrack BM; Lehman-McKeeman L; Salter-Cid LM; Xie J; Barrish JC; Carter PH; Dyckman AJ; Dhar TG
    J Med Chem; 2016 Nov; 59(21):9837-9854. PubMed ID: 27726358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-binding pocket shape differences between sphingosine 1-phosphate (S1P) receptors S1P1 and S1P3 determine efficiency of chemical probe identification by ultrahigh-throughput screening.
    Schürer SC; Brown SJ; Gonzalez-Cabrera PJ; Schaeffer MT; Chapman J; Jo E; Chase P; Spicer T; Hodder P; Rosen H
    ACS Chem Biol; 2008 Aug; 3(8):486-98. PubMed ID: 18590333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-like headgroup interactions.
    Gonzalez-Cabrera PJ; Jo E; Sanna MG; Brown S; Leaf N; Marsolais D; Schaeffer MT; Chapman J; Cameron M; Guerrero M; Roberts E; Rosen H
    Mol Pharmacol; 2008 Nov; 74(5):1308-18. PubMed ID: 18708635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of oxazole and triazole derivatives as potent and selective S1P(1) agonists through pharmacophore-guided design.
    Tian Y; Jin J; Wang X; Hu J; Xiao Q; Zhou W; Chen X; Yin D
    Eur J Med Chem; 2014 Oct; 85():1-15. PubMed ID: 25072873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis.
    Jin J; Hu J; Zhou W; Wang X; Xiao Q; Xue N; Yin D; Chen X
    Biochem Pharmacol; 2014 Jul; 90(1):50-61. PubMed ID: 24780445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Leu276 of the S1P1 receptor and Phe263 of the S1P3 receptor in interaction with receptor specific agonists by molecular modeling, site-directed mutagenesis, and affinity studies.
    Deng Q; Clemas JA; Chrebet G; Fischer P; Hale JJ; Li Z; Mills SG; Bergstrom J; Mandala S; Mosley R; Parent SA
    Mol Pharmacol; 2007 Mar; 71(3):724-35. PubMed ID: 17170199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist.
    Nakamura T; Asano M; Sekiguchi Y; Mizuno Y; Tamaki K; Kimura T; Nara F; Kawase Y; Shimozato T; Doi H; Kagari T; Tomisato W; Inoue R; Nagasaki M; Yuita H; Oguchi-Oshima K; Kaneko R; Watanabe N; Abe Y; Nishi T
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1788-92. PubMed ID: 22264485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes.
    Yan L; Huo P; Doherty G; Toth L; Hale JJ; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Bergstrom J; Card D; Quackenbush E; Wickham A; Mandala SM
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3679-83. PubMed ID: 16697189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S1P
    Birker-Robaczewska M; Bolli M; Rey M; de Kanter R; Kohl C; Lescop C; Boucher M; Poirey S; Steiner B; Nayler O
    Mol Pharmacol; 2018 Feb; 93(2):109-118. PubMed ID: 29203519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a 1-Methyl-3,4-dihydronaphthalene-Based Sphingosine-1-Phosphate (S1P) Receptor Agonist Ceralifimod (ONO-4641). A S1P
    Kurata H; Kusumi K; Otsuki K; Suzuki R; Kurono M; Komiya T; Hagiya H; Mizuno H; Shioya H; Ono T; Takada Y; Maeda T; Matsunaga N; Kondo T; Tominaga S; Nunoya KI; Kiyoshi H; Komeno M; Nakade S; Habashita H
    J Med Chem; 2017 Dec; 60(23):9508-9530. PubMed ID: 29120624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity.
    Scott FL; Clemons B; Brooks J; Brahmachary E; Powell R; Dedman H; Desale HG; Timony GA; Martinborough E; Rosen H; Roberts E; Boehm MF; Peach RJ
    Br J Pharmacol; 2016 Jun; 173(11):1778-92. PubMed ID: 26990079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and Structure-Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1).
    Gilmore JL; Sheppeck JE; Watterson SH; Haque L; Mukhopadhyay P; Tebben AJ; Galella MA; Shen DR; Yarde M; Cvijic ME; Borowski V; Gillooly K; Taylor T; McIntyre KW; Warrack B; Levesque PC; Li JP; Cornelius G; D'Arienzo C; Marino A; Balimane P; Salter-Cid L; Barrish JC; Pitts WJ; Carter PH; Xie J; Dyckman AJ
    J Med Chem; 2016 Jul; 59(13):6248-64. PubMed ID: 27309907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAR studies of 3-arylpropionic acids as potent and selective agonists of sphingosine-1-phosphate receptor-1 (S1P1) with enhanced pharmacokinetic properties.
    Yan L; Huo P; Hale JJ; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Bergstrom J; Card D; Mandala SM
    Bioorg Med Chem Lett; 2007 Feb; 17(3):828-31. PubMed ID: 17092714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indole-propionic acid derivatives as potent, S1P3-sparing and EAE efficacious sphingosine-1-phosphate 1 (S1P1) receptor agonists.
    Meng Q; Zhao B; Xu Q; Xu X; Deng G; Li C; Luan L; Ren F; Wang H; Xu H; Xu Y; Zhang H; Xiang JN; Elliott JD; Guo TB; Zhao Y; Zhang W; Lu H; Lin X
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2794-7. PubMed ID: 22429468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic, and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles.
    Skidmore J; Heer J; Johnson CN; Norton D; Redshaw S; Sweeting J; Hurst D; Cridland A; Vesey D; Wall I; Ahmed M; Rivers D; Myatt J; Giblin G; Philpott K; Kumar U; Stevens A; Bit RA; Haynes A; Taylor S; Watson R; Witherington J; Demont E; Heightman TD
    J Med Chem; 2014 Dec; 57(24):10424-42. PubMed ID: 25431977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.